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Introduction {#sec1}
============

Parkinson\'s disease (PD) is the second most common heterogenic degenerative brain disorder involving multiple etiologies. Various mechanisms have been implicated in PD neurodegeneration. The majority of cases are sporadic but certain cases are familial, driven by both genetic and environmental factors ([@bib18]; [@bib25]). It is primarily characterized by the specific degeneration of dopaminergic (DA) neurons in the substantia nigra (SN), where intraneuronal aggregates named Lewy bodies, are typically found. The major component of these protein-rich aggregates is the presynaptic protein α-Synuclein (α-Syn) ([@bib6]; [@bib18]; [@bib26]).

The ubiquitin/proteasome system (UPS) plays a central role in maintaining cellular homeostasis by degrading and recycling most intracellular proteins. A set of three different enzymes, E1 activating enzyme, E2 conjugating enzyme, and E3 ligase enzyme, act in a sequential manner to tag proteins with ubiquitin moieties and target them for proteasomal degradation ([@bib5]). Because UPS dysfunction leads to protein aggregation, and because protein aggregates in various neurodegenerative diseases (ND) frequently appear ubiquitin conjugated, it is assumed that the UPS function might be compromised in ND ([@bib29]). E3 ubiquitin ligases are responsible for substrate specificity, providing selectivity of target proteins for proteasomal degradation ([@bib5]). A large class of ubiquitin ligases is the E3 Skp1/Cullin1/F box protein (SCF). Whereas the S-phase kinase-associated protein 1 (Skp1) and Cullin1 are essentially invariable components of the SCF complexes, several dozens of distinct F box proteins exist, determining substrate specificity by binding to different protein substrates through protein-protein interaction domains, and to Skp1 through the F box domain, Skp1 in turn binds to Cullin1 ([@bib15]). Importantly, a robust decrement in the Skp1 gene and protein expression was detected in the SN of postmortem parkinsonian brains ([@bib12]; [@bib18]), and Skp1 protein has been listed among the predictive blood signatures with high discriminating power to categorize early PD patients ([@bib22]). Furthermore, mutations in an F box protein, FBXO7, were associated with autosomal recessive early onset of PD ([@bib8]). Whereas these findings highlight Skp1 as a potential important factor in PD, its function in both healthy and diseased human brains remains unclear.

*Drosophila* is a powerful model for studying the molecular and cell biological mechanisms of human diseases *in vivo* ([@bib9]; [@bib16]; [@bib19]; [@bib21]; [@bib24]). The *Drosophila* genome contains six *skp1* homologs (*skpA-F*), of which *skpA* shares the highest similarity with human *skp1* (76%) and is the most widely expressed. It was found to be necessary for larval growth and viability ([@bib23]). Different studies have implicated *skpA* in apoptosis regulation through ubiquitination of pro- and anti-apoptotic proteins ([@bib3]; [@bib10]), negative regulation of innate immunity ([@bib1]; [@bib14]), and guiding dendritic and axonal pruning during metamorphosis ([@bib28]). In fly models of polyQ neurodegenerative diseases, SkpA was reported to modify neurodegeneration in the eye, increasing aggregate load and toxicity upon eye-specific knockdown, implying possible involvement in pathogenesis of these ailments ([@bib4]). SkpA was also found to bind to the F box protein Nutcracker (Ntc), which was discovered in a screen for regulators of non-lethal caspase activation and sperm terminal differentiation in *Drosophila* ([@bib2]; [@bib3]). Ntc and its closest mammalian homolog, the PD-linked protein FBXO7, share 27% amino acid sequence similarity, which is much higher in the conserved active protein domains ([@bib20]). Consistent with the PD linkage of its human homolog, Ntc was recently shown to partially rescue climbing defects and precocious death in α-Syn-expressing flies proposing a similar role in neurodegeneration ([@bib20]).

Here we demonstrate that *skpA* is required for normal function of the adult brain; *skpA* knockdown in adult stage neurons increases aggregate load and causes loss of DA neurons accompanied by motor decline and shortened lifespan. Furthermore, we show that *skpA* overexpression significantly rescues neurodegeneration in α-Syn-induced fly PD model, as well as prevents accumulation of protein aggregates, improves motor ability and survival rate of wild-type flies, therefore uncovering a neuroprotective role of SkpA in the adult brain. We further reveal that SkpA interacts with Ntc and likely with alternative F box proteins emphasizing its central role in the degradation of neuronal proteins. Taken together, these findings implicate Skp1/SkpA as an important potential target for diagnosis and therapy in ND. Given that the human genome contains only one functional Skp1 isoform (Global Variome shared LOVD), our *in vivo* data place Skp1 at a strategic point for possible intervention in neurodegenerative processes.

Results {#sec2}
=======

*skpA* Is Specifically Expressed in Adult Brain Neurons {#sec2.1}
-------------------------------------------------------

To start exploring possible roles for SkpA in the adult brain, we first learned about its expression pattern in this tissue. For this, we examined flies carrying a *lacZ* exon trap insertion into the *skpA* locus (*skpA-lacZ*) and stained the dissected brains with anti-β-Gal antibodies. The glial and neuronal cells were respectively labeled with cytoplasmic GFP driven by the pan-glial *repoGal4* (*repoGal4*;*UAScytGFP*) ([Figures 1](#fig1){ref-type="fig"}A and 1C) and by staining with the neuron-specific anti-Elav antibody ([Figures 1](#fig1){ref-type="fig"}D and 1F). β-Gal, which designates the expression pattern of *skpA* ([Figures 1](#fig1){ref-type="fig"}B, 1C, 1E, and 1F), did not overlap with glial GFP ([Figure 1](#fig1){ref-type="fig"}C), but colocalized with Elav, indicating that in the adult fly brain *skpA* is specifically expressed in neurons but not in glial cells ([Figure 1](#fig1){ref-type="fig"}F).Figure 1*skPA* Is Specifically Expressed in Adult Brain NeuronsProjections from apotome stacks of whole-mount entire brains of 5-day-old females developed at 29°C. (A--C) *skpA-lacZ/*+;*tubGal80*^*ts*^; *repoGal4*,*UAScytGFP*.(A) Glial cells are labeled with GFP in green.(B) *skpA* expression is marked in magenta by an anti-β-Gal antibody.(C) No overlap is detected between glial cells and β-Gal expression (arrows).(D--F) *skpA-lacZ/FM7*. (D) Neurons are labeled with an anti-Elav antibody in green. (E) *skpA* expression is marked by the anti-β-Gal antibody in magenta. (F) An overlap between β-Gal and Elav immunostaining indicates *skpA* expression in neurons (arrowheads). Bar: 50 μm.

Lack of *skpA* in Adult Brain Neurons Leads to Neurodegeneration {#sec2.2}
----------------------------------------------------------------

*skpA* is required for normal fly development and its null mutants are lethal ([@bib23]). Therefore, to study *skpA* role in the adult brain, we knocked down its expression in neurons using the pan-neural driver *elavGal4* or the DA neuron-specific driver *Tyrosine Hydroxylase* (*TH*)*Gal4*. To restrict *skpRNAi* expression to the adult stage, we used a ubiquitous temperature-sensitive allele of the Gal80 repressor, which can be inhibited at 29°C. We kept crosses at 18°C to repress Gal4 expression by Gal80 and transferred the descendants to 29°C during the first day post-eclosion (DPE) to allow Gal4-induced RNAi expression. We then evaluated brain function following pan-neural *skpA* knockdown or DA neuron-specific knockdown by testing climbing ability and survival rate ([Figure 2](#fig2){ref-type="fig"}). Both genotypes exhibited strong motor deficit ([Figure 2](#fig2){ref-type="fig"}A) and shortened lifespan ([Figure 2](#fig2){ref-type="fig"}B), as compared with control flies ([Figures 2](#fig2){ref-type="fig"}A and 2B), indicating a critical role of SkpA in the adult fly brain. It is noteworthy that the effects caused by the pan-neural knockdown were more pronounced than those caused by the DA neuron-specific knockdown, as the flies exhibited steeper decline in climbing performance and a more severe reduction in lifespan ([Figures 2](#fig2){ref-type="fig"}A and 2B), indicating that other neuronal types are also involved in motor activity and that SkpA functions in different neuronal populations.Figure 2*skpA* Knockdown in Adult Brain Neurons Causes Accumulation of Ubiquitin-Tagged Protein Aggregates and Neuronal Loss Accompanied by Reduced Climbing Ability and Survival Rate(A and B) (A) Climbing ability and (B) survival rate of flies expressing *skpARNAi* in a pan-neural manner (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpARNAi*) (blue) or in DA neurons alone (*THGal4/*+;*tubGal80*^*ts*^*/UASskpARNAi*) (red) compared with control flies (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (black) at 29°C from 1 DPE. (A) Transgenic flies expressing *skpARNAi* in all neurons display a higher decline in climbing ability as compared with flies expressing *skpARNAi* in DA neurons. (B) Transgenic flies expressing *skpARNAi* in a pan-neural pattern present a shorter lifespan compared with flies expressing *skpARNAi* in DA neurons alone. n = 12 represents the number of vials per genotype.(C and D) Projections from apotome stacks of the posterior part (∼45μm) of whole-mount female brains 22 DPE. (C) Control (*elavGal4/*+;*tubGal80*^*ts*^*/*+). (D) Transgenic fly expressing *skpARNAi* in a pan-neural pattern (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpARNAi*). DA neurons are labeled with an anti-TH antibody (red). Bar: 50 μm.(E) The mean total numbers of DA neurons in transgenic female flies at different ages expressing *skpARNAi* specifically in adult brain neurons (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpARNAi*); n = 8 for 1 DPE, n = 5 for 8 DPE, n = 7 for 15 DPE, and n = 6 for 22 DPE. n = 13 for control (*elavGal4/*+;*tubGal80*^*ts*^*/*+).(F and G) Projections from apotome stacks of whole-mount entire female brains 25 DPE. (F) Control (*elavGal4/*+;*tubGal80*^*ts*^*/*+). (G) Transgenic fly expressing *skpARNAi* in a pan-neural pattern (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpARNAi*). Ubiquitinated proteins in the adult brains (posterior view) are detected with an anti-Ub antibody (red). Bar: 50 μm.(H) The mean total number of aggregates within apotome stacks of adult brains. n = 6 for control, n = 7 for *skpA* knockdown fly brains. Data are represented as mean ± SEM. Statistical significance was analyzed employing two-way ANOVA or students\' t test, ∗∗∗∗p \< 0.0001, ∗∗∗p \< 0.001, ∗p \< 0.05, n.s. = non-significant.

Pan-neural *skpA* Knockdown in the Adult Brain Reduces the Number of DA Neurons {#sec2.3}
-------------------------------------------------------------------------------

To better understand how *skpA* inactivation affects motor functions and lifespan, we quantified the number of DA neurons in the adult brain following pan-neural *skpA* knockdown. The DA neurons were labeled with an anti-TH antibody, and the brains were monitored at different time points following *skpARNAi* expression ([Figures 2](#fig2){ref-type="fig"}C--2E). Both our and other\'s previous work showed that the number of DA neurons does not change during adult stages ([@bib7]; [@bib27]); therefore, we included only one control age for clarity ([Figure 2](#fig2){ref-type="fig"}E). Although the number of DA neurons in the knockdown was similar to that in control brains during the first two weeks of *skpARNAi* expression, their number significantly declined as comparted with the control at 22 DPE ([Figure 2](#fig2){ref-type="fig"}E). Interestingly, the impaired climbing ability was observed earlier than the reduction in the number of DA neurons ([Figures 2](#fig2){ref-type="fig"}A and 2E), suggesting that other neuronal cell types might be involved in locomotor function or that the DA neurons become dysfunctional prior to their complete loss.

Pan-neural *skpA* Knockdown Increases Accumulation of Ubiquitin-Conjugated Proteins {#sec2.4}
-----------------------------------------------------------------------------------

SkpA is a core component of E3 ligase, playing a major role in protein ubiquitination followed by proteasomal degradation. Aggregation of ubiquitinated proteins is a landmark of many ND. We therefore hypothesized that the neuronal loss observed in the *skpA* knockdown could be linked to increased aggregate load in the brain. To test this idea, we detected ubiquitin-conjugated proteins using an anti-Ubiquitin (Ub) antibody and quantified labeled aggregates. A significantly higher number of aggregates was found in brains of *skpA* knockdown flies compared with control fly brains ([Figures 2](#fig2){ref-type="fig"}F--2H), indicating that SkpA function is required for proper degradation of ubiquitin-conjugated proteins in adult brain neurons.

*skpA* Overexpression in the Adult Fly Brain Improves Locomotor Performance and Prolongs Lifespan {#sec2.5}
-------------------------------------------------------------------------------------------------

Our findings that *skpA* is required for healthy brain function prompted us to examine the effect of increased *skpA* expression specifically in the adult brain. For this, we used the *elavGal4* driver and *tubGal80* repressor to drive overexpression of *skpA* specifically in the adult stage neurons by transferring the flies to the Gal80 restrictive temperature after eclosion. Strikingly, locomotor performance and lifespan of these flies were significantly increased compared with control flies ([Figures 3](#fig3){ref-type="fig"}A and 3B), supporting the important role of SkpA in the adult brain neurons and suggesting that its higher amount could be beneficial for adult brain function.Figure 3Overexpression of *skpA* in Adult Brain Neurons Reduces Amount of Ubiquitin-Tagged Protein Aggregates and Improves Motor Ability and Survival Rate(A and B) (A) Climbing ability and (B) survival rate of flies overexpressing *skpA* in all brain neurons (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpA*) (violet) compared with control flies (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (black) at 29°C from 1 DPE. n = 6 represents the number of vials.(C and D) The mean total numbers of (C) DA neurons and (D) ubiquitin-labeled protein aggregates within apotome stacks of adult female brains. (C) Flies overexpressing *skpA* (n = 9) exhibit no significant difference in the number of DA neurons as compared with control flies (n = 13) at 22 DPE. (D) Flies overexpressing *skpA* (n = 9) exhibit a significantly lower number of protein aggregates compared with control (n = 6). Data are represented as mean ± SEM. Statistical significance was analyzed employing students\' t test, ∗∗∗∗p \< 0.0001, ∗∗p \< 0.01, n.s. = non-significant.

*skpA* Overexpression in the Adult Fly Brain Prevents Accumulation of Protein Aggregates {#sec2.6}
----------------------------------------------------------------------------------------

To examine the connections between the improved climbing ability, increased survival rate, DA neurons number, and protein aggregate load, we quantified DA neurons and aggregate numbers using the anti-TH and anti-Ub antibodies, respectively ([Figures 3](#fig3){ref-type="fig"}C and 3D). Interestingly, although no significant difference was found in the number of DA neurons in fly brains overexpressing *skpA* compared with control brains ([Figure 3](#fig3){ref-type="fig"}C), the number of aggregates was significantly lower in the flies overexpressing *skpA* ([Figure 3](#fig3){ref-type="fig"}D). This suggests that the improved locomotion and survival rate are not the result of changes in the numbers of the DA neurons but are rather attributed to the enhancement in the degradation of ubiquitinated proteins.

*skpA* Overexpression Recovers Neurodegeneration in the Adult Fly PD Model {#sec2.7}
--------------------------------------------------------------------------

Many studies have suggested and demonstrated the relevance of Skp1 to both development and progression of PD in humans ([@bib12]; [@bib18]; [@bib22]). This prompts us to study the role of SkpA in a *Drosophila* model mimicking PD. For this, we used transgenic flies that represent an adult α-Syn-induced PD model ([@bib7]). To study the effect of SkpA on the PD model, we examined flies simultaneously expressing human *α-syn* with *skpA* in the adult brain neurons. We found that both climbing ability ([Figure 4](#fig4){ref-type="fig"}A) and survival rate ([Figure 4](#fig4){ref-type="fig"}B) were significantly improved as a result of *skpA* overexpression, indicating that SkpA rescues PD-model-associated neurodegeneration phenotype. Moreover, consistent with these results, the number of ubiquitin-conjugated protein aggregates and DA neurons were reverted to the control numbers ([Figures 4](#fig4){ref-type="fig"}C and 4D). These data demonstrate that *skpA* overexpression rescues α-Syn-induced neurodegeneration phenotype, revealing again the protective role of SkpA in the adult brain.Figure 4*skpA* Neuronal Overexpression Inhibits Neurodegeneration in the Adult Fly PD Model(A and B) (A) Climbing ability and (B) survival rate of adult PD model flies, expressing human *α-syn* in all brain neurons (*elavGal4/UASα-syn*; *tubGal80*^*ts*^*/+*) (orange) or PD model flies simultaneously overexpressing *skpA* (*elavGal4/UASα-syn*;*tubGal80*^*ts*^*/UASskpA*) (green) in all brain neurons. Control flies (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (black). *skpA* overexpression improves climbing ability and increases lifespan compared with *α-syn* transgenic flies. n = 3 represents the number of vials.(C and D) The mean total numbers of (C) DA neurons and (D) Ub-labeled protein aggregates within apotome stacks of adult female brains. Control (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (n = 13 and n = 6); flies overexpressing *skpA* (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpA*) (n = 9 and n = 8); adult fly PD model (*elavGal4/UASα-syn*;*tubGal80*^*ts*^*/*+) (n = 12 and n = 6); adult fly PD model carrying neuronal expression of *skpA* (*elavGal4/UASα-syn*;*tubGal80*^*ts*^*/UASskpA*) (n = 9 and n = 8). Data are represented as mean ± SEM. Statistical significance was analyzed employing two-way ANOVA, ∗∗∗∗p \< 0.0001, ∗∗p \< 0.01, ∗p \< 0.05, n.s. = non-significant.

Lack of the Ntc Causes Neurodegeneration {#sec2.8}
----------------------------------------

SkpA/Skp1 interacts with various F Box proteins in different tissues. One of *Drosophila* SkpA-interacting F Box proteins is Ntc, which was previously shown to affect α-Syn-expressing flies ([@bib20]). To test the role of Ntc in the fly brain, we first evaluated neurodegeneration in *ntc*^*ms771*^ mutant flies that carry a premature stop codon in the *ntc* sequence that deletes the entire F box domain ([@bib3]). These flies were barely able to climb and completely lost this ability in a few days ([Figure 5](#fig5){ref-type="fig"}A), whereas wild-type flies continued climbing for more than 40 DPE ([Figure 5](#fig5){ref-type="fig"}A). Moreover, the mutants did not survive more than 10 days compared with wild-type flies that live over 2 months at 25°C ([Figure 5](#fig5){ref-type="fig"}B). Thus, these results show that the F Box protein Ntc contributes to adult brain maintenance as SkpA.Figure 5Altered Levels of *ntc* in Adult Brain Neurons Cause Neurodegeneration(A and B) (A) Climbing ability and (B) survival rate of control flies (*w*^*1118*^) (black) and *ntc* mutant flies (*ntc*^*ms771*^/*ntc*^*ms771*^) (green) from 1 DPE at room temperature. n = 3 represents the number of vials.(C and D) (C) Climbing ability and (D) survival rate of flies expressing *ntcRNAi* (*elavGal4/*+;*tubGal80*^*ts*^*/UASntcRNAi*) (blue) or overexpressing *ntc* (*elavGal4/*+;*tubGal80*^*ts*^*/UASntcHA*) (pink) in a pan-neural manner compared with control flies (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (black) at 29°C from 1 DPE. n = 6 represents the number of vials.(E and F) The mean total numbers of (E) DA neurons and (F) Ub-labeled protein aggregates within apotome stacks of adult female brains. Control (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (n = 13 and n = 6); (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/+*) (n = 6 and n = 8); (*elavGal4/+*;*tubGal80*^*ts*^*/UASntcHA*) (n = 9 and n = 10). Data are represented as mean ± SEM. Statistical significance was analyzed employing students\' t test or two-way ANOVA, ∗∗∗∗p \< 0.0001, ∗p \< 0.05, n.s. = non-significant.

The Level of *ntc* Expression Is Critical for Adult Brain Function {#sec2.9}
------------------------------------------------------------------

To further understand the role of *ntc* in the adult brain we knocked it down by RNAi or increased its expression specifically in all brain neurons at the adult stage. Interestingly, both manipulations, *ntc* knockdown and overexpression, resulted in reduced locomotor ability and shortened lifespan ([Figures 5](#fig5){ref-type="fig"}C and 5D), whereas the knockdown (blue curve) caused a steeper decline in both climbing ability and survival rate compared with the overexpression (pink curve). Remarkably, in the *ntc* knockdown fly brains, a lower number of DA neurons was detected than in control ([Figure 5](#fig5){ref-type="fig"}E); however, the number of protein aggregates was not different ([Figure 5](#fig5){ref-type="fig"}F). Conversely, *ntc* overexpression did not change the number of DA neurons ([Figure 5](#fig5){ref-type="fig"}E) but significantly increased the number of protein aggregates ([Figure 5](#fig5){ref-type="fig"}F). These data demonstrate that either the lack or the excess of *ntc* is detrimental to the adult brain, indicating that the level of *ntc* expression must be tightly regulated for proper brain function.

*skpA* and *ntc* Genetically Interact in the Adult Brain Neurons {#sec2.10}
----------------------------------------------------------------

Neuron-specific knockdown of *skpA* or *ntc* causes a comparable phenotype, suggesting that the two proteins could work in the same pathway. To test whether *skpA* and *ntc* genetically interact, we simultaneously knocked them down in adult brain neurons and examined the climbing ability ([Figure 6](#fig6){ref-type="fig"}A) and survival rate of the flies ([Figure 6](#fig6){ref-type="fig"}B) in comparison to each single gene knockdown ([Figures 6](#fig6){ref-type="fig"}A and 6B). The concurrent knockdown of both genes led to a similar phenotype ([Figures 6](#fig6){ref-type="fig"}A and 6B). Moreover, no significant difference in the number of DA neurons and ubiquitinated protein aggregates was observed between *skpA* knockdown alone and the double knockdown ([Figures 6](#fig6){ref-type="fig"}C and 6D), revealing no additive effect. These results suggest that the two proteins likely work together.Figure 6*skpA* and *ntc* Genetically Interact in Adult Brain Neurons and Rescue Each Other\'s Neurodegeneration Phenotype(A and B) (A) Climbing ability and (B) survival rate of flies carrying *skpA* knockdown (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpARNAi*) (dark blue) or *ntc* knockdown (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/+*) (light blue) or both (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/UASskpARNAi*) (red) simultaneously. Control (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (black). n = 6 represents the number of vials.(C and D) The mean total numbers of (C) DA neurons and (D) Ub-labeled protein aggregates within apotome stacks of adult female brains. Control (n = 13 and n = 6); (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/+*) (n = 8 and n = 6); (*elavGal4/+*;*tubGal80*^*ts*^*/UASskpARNAi*) (n = 6 and n = 6); (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/UASskpARNAi*) (n = 8 and n = 11).(E and F) (E) Climbing ability and (F) survival rate of flies carrying *ntc* knockdown (*elavGal4/*+;*tubGal80*^*ts*^*/UASntcARNAi*) (light blue) or *ntc* knockdown and *skpA* overexpression (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/UASskpA*) (brown). Control (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (black). n = 6 represents the number of vials.(G and H) The mean total numbers of (G) DA neurons and (H) Ub-labeled protein aggregates within apotome stacks of adult female brains. Control (n = 13 and n = 6); (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/+*) (n = 6 and n = 8); (*elavGal4/UASntcRNAi*;*tubGal80*^*ts*^*/UASskpA*) (n = 6 and n = 10).(I and J) (I) Climbing ability and (J) survival rate of flies carrying *skpA* knockdown (*elavGal4/*+;*tubGal80*^*ts*^*/UASskpARNAi*) (dark blue) or *skpA* knockdown and *ntc* overexpression (*elavGal4/UASntcHA*;*tubGal80*^*ts*^*/UASskpARNAi*) (pink). Control (*elavGal4/*+;*tubGal80*^*ts*^*/*+) (black). n = 6 represents the number of vials.(K and L) The mean total numbers of (K) DA neurons and (L) Ub-labeled protein aggregates within apotome stacks of adult female brains. Control (n = 13 and n = 6); (*elavGal4/UASskpARNAi*;*tubGal80*^*ts*^*/+*) (n = 6 and n = 6); (*elavGal4/UASntcHA*;*tubGal80*^*ts*^*/UASskpARNAi*) (n = 6 and n = 8).Data are represented as mean ± SEM. Statistical significance was analyzed employing two-way ANOVA, ∗∗∗∗p \< 0.0001, ∗∗∗p \< 0.001, ∗∗p \< 0.01, ∗p \< 0.05, n.s. = non-significant.

*skpA* and *ntc* Mutually Rescue Neurodegeneration Phenotype of Each Other {#sec2.11}
--------------------------------------------------------------------------

To further explore the genetic interactions between *skpA* and *ntc* in the adult brain, we carried out rescue experiments of *ntc* knockdown by overexpression of *skpA* and vice versa. As shown in [Figure 6](#fig6){ref-type="fig"}, the overexpression of *skpA* in adult brain neurons rescued the phenotype of *ntc* knockdown. The climbing activity and lifespan were significantly improved in flies overexpressing *skpA*, compared with flies carrying only *ntc* RNAi ([Figures 6](#fig6){ref-type="fig"}E and 6F). Moreover, *skpA* overexpression significantly increased the number of DA neurons ([Figure 6](#fig6){ref-type="fig"}G) and reduced the amount of ubiquitin-conjugated protein aggregates ([Figure 6](#fig6){ref-type="fig"}H) in flies expressing *ntcRNAi* compared with *ntc* knockdown alone ([Figures 6](#fig6){ref-type="fig"}G and 6H). These data strongly suggest that SkpA may act through an additional pathway(s) comprising another F box protein(s).

Specific overexpression of *ntc* in adult brain neurons carrying *skpARNAi* significantly rescued *skpA* knockdown phenotype, namely, climbing ability and survival rate of these flies were significantly improved compared with transgenic flies expressing *skpARNAi* alone ([Figures 6](#fig6){ref-type="fig"}I and 6J, pink curve compared with dark blue curve). Consistent with these data, the number of DA neurons in brains of *skpA* knockdown flies overexpressing *ntc* was significantly higher than in *skpA* knockdown alone ([Figure 6](#fig6){ref-type="fig"}K). Importantly, no significant change in aggregate load was detected ([Figure 6](#fig6){ref-type="fig"}L). These results further support our notion that SkpA and Ntc act in the same pathway.

Discussion {#sec3}
==========

The molecular mechanisms underlying ND are mainly unknown. Finding biomarkers for timely diagnostics of these diseases as well as potential targets for therapeutic intervention requires identifying critical players in the processes leading to neurodegeneration. Our study uncovers the central role of the *Drosophila* Skp1 homolog, SkpA, in adult brain function and depicts it as a potential biomarker and therapeutic target in neurodegenerative processes.

In this work, we show that *skpA* is specifically expressed in the adult brain neurons and that its targeted knockdown in the adult brain leads to accumulation of ubiquitinated protein aggregates and loss of DA neurons accompanied by motor dysfunction and shortened lifespan. This neurodegeneration phenotype demonstrates that SkpA is required for protein degradation in neurons, a process essential for brain health. In consistence with this, we discovered that overexpression of *skpA* specifically in adult brain neurons prevents accumulation of protein aggregates, prolongs fly lifespan, and hinders the age-related motor decline. These exciting data place SkpA in a strategic position regulating neuroprotective pathways. Interestingly, no significant difference was found in the number of DA neurons between flies overexpressing *skpA* in the adult brain and control flies, suggesting that the gain of survival rate and motor ability is not specifically related to the number of DA neurons in the brain but rather to their proper function. It can also suggest that other types of neurons are involved in age-related motor decline. In accordance with this, we have recently shown that climbing ability of flies can be improved regardless of change in the number of DA neurons ([@bib13]). Because SkpA is widely expressed in the adult brain neurons, we suggest that it functions in diverse neuronal cell types.

Previous studies describing association of *skp1* and parkinsonism and the potential implication of *skp1* in proper function and viability of DA neurons ([@bib11]; [@bib17]) prompted us to examine the role of SkpA in the fly model of PD ([@bib7]). We found that *skpA* overexpression partially rescued neurodegeneration in PD-like flies, demonstrating that increased levels of *skpA* accelerate evacuation of ubiquitinated protein aggregates. The protection afforded by *skpA* overexpression supports the conclusion regarding its potential to serve as a target for therapeutic intervention.

To gain a deeper insight into the molecular mechanisms of SkpA function in the adult brain, we investigated the role of the F box protein Ntc in neurodegeneration. Although Ntc and SkpA interaction has been implicated in the sperm differentiation process ([@bib3]) and Ntc was recently shown to affect α-Syn-expressing flies ([@bib20]), no studies have analyzed whether these proteins interact/cooperate in the adult brain. Interestingly, reduced or increased levels of *ntc* affect fly motor ability and survival rate, suggesting that the amount of Ntc is critical in the adult brain. However, *ntc* knockdown, which causes a strong neurodegeneration phenotype, does not affect the number of ubiquitin-tagged protein aggregates. These results suggest that Ntc might be required for protein ubiquitination and, therefore, the anti-Ub antibodies do not recognize unlabeled protein aggregates in the *ntc* knockdown brains. Consistently with this suggestion, *ntc* overexpression probably leads to surplus ubiquitination, which is pronounced in slightly higher number of Ub-labeled protein aggregates. This off-target ubiquitination may cause excess protein degradation and affect other neurons than DA (the number of DA neurons remains normal under *ntc* overexpression), leading to the reduced climbing and survival phenotype.

Based on our data we suggest a working model ([Figure 7](#fig7){ref-type="fig"}) in which SkpA and Ntc are required for proper protein degradation in adult brain neurons. The genetic interaction and rescue experiments reveal that SkpA and Ntc likely act in the same pathway, where Ntc is mostly involved in ubiquitination of substrates and SkpA is subsequently required for their proteasomal degradation ([Figure 7](#fig7){ref-type="fig"}A). Such a model might explain why in *skpA* knockdown flies we detect an accumulation of Ub-labeled aggregates ([Figure 7](#fig7){ref-type="fig"}B), which is not seen in *ntc* knockdown ([Figure 7](#fig7){ref-type="fig"}C). Because *ntc* overexpression partially rescues *skpA* knockdown, it might occur due to increased ubiquitination, which allows degradation of tagged substrates even when SkpA levels are reduced. Conversely, *skpA* overexpression partially rescues *ntc* knockdown phenotype, suggesting that SkpA interacts with additional F box proteins in the adult brain (\"F box?\", [Figure 7](#fig7){ref-type="fig"}). It will be interesting to test potential candidates in future experiments. Our study reveals the critical role of SkpA in neuronal maintenance, which likely functions as a bottleneck in the protein degradation processes, whose dysregulation could lead to formation of aggregates. Collectively, this discloses a substantial potential of SkpA/Skp1 as a diagnostic marker and therapeutic target in ND. The parallel role of SkpA/Skp1 in the brain function of flies and mammals indicates that modeling neurodegeneration in *Drosophila* continues to provide paradigms that can guide clinical research.Figure 7Model Summarizing SkpA and Ntc Interactions in the Adult Fly Brain(A) A suggested model for ubiquitin-mediated protein degradation in the adult fly brain. Our data propose that Ntc and SkpA act in the same pathway. Ntc is mostly involved in substrate ubiquitination, whereas SkpA likely sends already ubiquitinated proteins to proteasomal degradation.(B) *skpA* knockdown leads to accumulation of ubiquitinated protein aggregates, which are detected with the anti-Ub antibody. It also reduces the number of DA neurons, climbing ability, and survival rate.(C) *ntc* knockdown reduces the number of DA neurons accompanied by declined climbing ability and shortened lifespan; however, no increase in the number of the ubiquitin-tagged protein aggregates is detected. We suggest that Ntc might be involved in protein ubiquitination, and therefore, its knockdown causes an accumulation of unubiquitinated proteins, which are not detected with the anti-Ub antibody.(D) *skpA* overexpression accelerates degradation of ubiquitinated proteins resulting in significantly lower number of Ub-labeled aggregates than in control, accompanied by improved climbing ability and increased survival rate.(E) Overexpression of *ntc* outcomes slightly increased number of Ub-labeled protein aggregates but does not affect the number of DA neurons (see [Figure 5](#fig5){ref-type="fig"}E) because SkpA normally degrades the ubiquitinated substrates. Weak reduction in climbing ability and shortened lifespan may result from degradation of off-target substrates or sequestration of SkpA by the elevated Ntc. The excess of Ntc may engage SkpA and prevent its function in additional pathway(s), leading to weak neurodegeneration phenotype.

Limitations of the Study {#sec3.1}
------------------------

Our data suggest that Ntc is required for ubiquitination of neuronal proteins in the adult brain; however, because there are no available antibodies/reagents that recognize non-ubiquitinated aggregates we could not demonstrate their accumulation in the brains of *ntc* knockdown. Our results also suggest that SkpA interacts with additional F box protein(s) that are yet to be identified and beyond the scope of this research.

Resource Availability {#sec3.2}
---------------------

### Lead Contact {#sec3.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Estee Kurant (<ekurant@univ.haifa.ac.il>)

### Materials Availability {#sec3.2.2}

All reagents generated in this study will be made available on request to the Lead Contact; however, requestor will cover shipping costs. This study did not generate new unique reagents.

### Data and Code Availability {#sec3.2.3}

The original/source data are available from the lead contact on request.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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